熱門資訊> 正文
Twist Bioscience 2025年第三季度盈利预测
2025-08-01 22:47
- Twist Bioscience (NASDAQ:TWST) is scheduled to announce Q3 earnings results on Monday, August 4th, before market open.
- The consensus EPS Estimate is -$0.57 and the consensus Revenue Estimate is $95.64M (+17.3% Y/Y).
- Over the last 2 years, TWST has beaten EPS estimates 88% of the time and has beaten revenue estimates 88% of the time.
- Over the last 3 months, EPS estimates have seen 1 upward revision and 1 downward. Revenue estimates have seen 2 upward revisions and 3 downward.
More on Twist Bioscience
- Twist Bioscience: Still Not There Yet
- Twist Bioscience: Expansion Efforts Continue To Face Challenges
- Twist Bioscience and Ginkgo Bioworks update 2022 partnership
- Twist bioscience outlines adjusted EBITDA breakeven by fiscal 2026 with revenue growth targets
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
